| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5887727 | Seminars in Arthritis and Rheumatism | 2013 | 7 Pages | 
Abstract
												In our cohort, no clinical manifestation or disease score could clearly select patients with subsequent lymphoma development. Presence of IgM-kappa clonal components and development of purpura, PNP, and GN should alert the clinician for the presence of lymphoma.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Anesthesiology and Pain Medicine
												
											Authors
												Anna P. MD, Aike A. MD, PhD, Johannes W.J. MD, PhD, 
											